HIGHLIGHTS
- who: Xing Zhang and collaborators from the Medical University of Lublin, Poland have published the research: Glucose transporters: Important regulators of endometrial cancer therapy sensitivity, in the Journal: (JOURNAL)
- future: How to achieve an efficient synergistic effect of GLUT inhibitors and hormone therapy may be a focus of future research. the other trial concerning pembrolizumab radiation and immune modulation is still ongoing .
SUMMARY
In type 2 diabetes, this may induce GLUT4 expression and plasma_membrane GLUT4 translocation in adipocytes. PGRMC1 can stimulate the expression of insulin receptors (IRs) in the plasma_membrane and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.